Jon Coffman, PhD Boehringer Ingelheim

Dr. Jon Coffman is Global Head Innovation, Technology at Boehringer Ingelheim in Fremont, California. Jon and his team are instrumental in driving the implementation of BI’s bioprocessing innovation vision.

Jon is an internationally recognized expert in bioprocess and technology development. Jon has more than 25 years of industry experience, mostly from his work at Genetics Institute/Wyeth and Pfizer, and now at Boehringer Ingelheim. Prior to 2009 Jon led a team in the area of downstream purification development, as well as CMC drug development teams. From 2009 on, as Associate Research Fellow, he coordinated Technology and Innovation for Bioprocess R&D, and led Pfizer’s monoclonal on demand team, developing concepts for faster, lower cost antibody process development.

At BI, Jon heads the global innovation program in Biopharma, evaluating and guiding technology development in analytical, upstream, downstream, and formulation. He also leads a group of upstream and downstream scientists developing an integrated manufacturing platform in collaboration with Pfizer.